Reduced number of subcutaneous adipocytes and metabolic disorders in patients with pulmonary emphysema.
T. Tsuji (Tokyo, Japan), K. Imai (Tokyo, Japan), R. Kikuchi (Tokyo, Japan), K. Furukawa (Ibaraki, Japan), K. Toriyama (Tokyo, Japan), M. Ishiwari (Tokyo, Japan), C. Yajima (Tokyo, Japan), J. Kawagoe (Tokyo, Japan), Y. Togashi (Tokyo, Japan), H. Nakamura (Ibaraki, Japan), K. Yamaguchi (Tokyo, Japan), K. Aoshiba (Ibaraki, Japan), S. Abe (Tokyo, Japan)
Source: International Congress 2019 – Comorbidities in COPD and asthma: body composition and diabetes
Disease area: Airway diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
T. Tsuji (Tokyo, Japan), K. Imai (Tokyo, Japan), R. Kikuchi (Tokyo, Japan), K. Furukawa (Ibaraki, Japan), K. Toriyama (Tokyo, Japan), M. Ishiwari (Tokyo, Japan), C. Yajima (Tokyo, Japan), J. Kawagoe (Tokyo, Japan), Y. Togashi (Tokyo, Japan), H. Nakamura (Ibaraki, Japan), K. Yamaguchi (Tokyo, Japan), K. Aoshiba (Ibaraki, Japan), S. Abe (Tokyo, Japan). Reduced number of subcutaneous adipocytes and metabolic disorders in patients with pulmonary emphysema.. 4313
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: